Metabolic Disorder in Chronic Obstructive Pulmonary Disease (COPD) Patients: Towards a Personalized Approach Using Marine Drug Derivatives

Author： Lamonaca Palma   Prinzi Giulia   Kisialiou Aliaksei   Cardaci Vittorio   Fini Massimo   Russo Patrizia  

Publisher： MDPI

E-ISSN： 1660-3397|15|3|81-81

ISSN： 1660-3397

Source： Marine Drugs, Vol.15, Iss.3, 2017-03, pp. : 81-81

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemokine Receptors in Chronic Obstructive Pulmonary Disease (COPD)

By  

Current Drug Targets, Vol. 7, Iss. 6, 2006-06 ,pp. : 669-674

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidants in Asthma and in Chronic Obstructive Pulmonary Disease (COPD)

By  

Current Pharmaceutical Design, Vol. 11, Iss. 16, 2005-06 ,pp. : 2053-2062

Bentham Science Publishers

Access to resources Recommend Favorite

Chronic obstructive pulmonary disease (COPD) may represent a serious threat

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 254, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Ghrelin is promising for chronic obstructive pulmonary disease (COPD)-associated cachexia

By  

Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Mechanisms of Corticosteroid Resistance in Severe Asthma and Chronic Obstructive Pulmonary Disease (COPD)

By  

Current Pharmaceutical Design, Vol. 16, Iss. 32, 2010-11 ,pp. : 3554-3573

Bentham Science Publishers

Access to resources Recommend Favorite